Home NDC 42291-017 ACYCLOVIR
Product NDC 42291-017
11-digit product format 422910017
Labeler code 42291
Product ID 42291-017_d5792e8c-ee12-64a5-e053-2a95a90ad2fb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ACYCLOVIR
Dosage form CAPSULE
Route ORAL
Labeler AvKARE
Application ANDA075677
Marketing category ANDA
Marketing start 2019-01-15
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 200 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42291-017 ACYCLOVIR CAPSULE [AVKARE] 3 Legacy NDC 20240110_7f81a1d5-1498-3890-e053-2a91aa0aee6a.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 42291-017-01 42291001701 100 CAPSULE in 1 BOTTLE (42291-017-01) 100 capsule 2019-01-15 0000-00-00 No No Current 42291-017-50 42291001750 500 CAPSULE in 1 BOTTLE (42291-017-50) 500 capsule 2019-01-15 0000-00-00 No No Current